Description

Proposed therapeutic strategy combining mitophagy-promoting and biogenesis-enhancing compounds to combat mitochondrial dysfunction in dry AMD outlines a multi-target approach.

Figure 7

Diagram

Source Paper

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration.

Nutrients (2022)

PMID: 35565950

DOI: 10.3390/nu14091985

Cite This Figure

![Figure 7: Proposed therapeutic strategy combining mitophagy-promoting and biogenesis-enhancing compounds to combat mitochondrial dysfunction in dry AMD outlines a multi-target approach.]()

> Source: Lidianys María Lewis Luján et al. "Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat." *Nutrients*, 2022. PMID: [35565950](https://pubmed.ncbi.nlm.nih.gov/35565950/)

<figure>
  <img src="" alt="Proposed therapeutic strategy combining mitophagy-promoting and biogenesis-enhancing compounds to combat mitochondrial dysfunction in dry AMD outlines a multi-target approach." />
  <figcaption>Figure 7. Proposed therapeutic strategy combining mitophagy-promoting and biogenesis-enhancing compounds to combat mitochondrial dysfunction in dry AMD outlines a multi-target approach.<br>  Source: Lidianys María Lewis Luján et al. "Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35565950/">35565950</a></figcaption>
</figure>

Related Evidence

Astaxanthin for Oxidative Stress

Grade C · 3 studies